American Kidney Fund Recognized as a Top Nonprofit Workplace in the United States
April 23, 2024 09:40 ET
|
American Kidney Fund
ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce that it has been selected as one of the top 50 nonprofit employers in the United States by...
American Kidney Fund Awards Fellowships to Researchers Studying Acute Interstitial Nephritis and Pulmonary Hypertension in Kidney Patients
April 11, 2024 08:47 ET
|
American Kidney Fund
ROCKVILLE, Md., April 11, 2024 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) announced the recipients of this year’s Clinical Scientist in Nephrology (CSN) fellowship program, in which...
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 10, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated Kidney Disease (AMKD) on Capitol Hill
April 09, 2024 08:51 ET
|
American Kidney Fund
ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy...
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
March 28, 2024 16:15 ET
|
Unicycive Therapeutics, Inc.
– Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose...
Diabetic Kidney Disease Global Market Research Report 2024
March 25, 2024 11:05 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Kidney Disease Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The diabetic kidney disease market size...
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
March 25, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
American Kidney Fund Launches Phosphorus Management Education and Awareness Campaign
March 19, 2024 09:15 ET
|
American Kidney Fund
ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a new patient-focused educational awareness campaign on managing high phosphorus, also known as...
American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22
March 18, 2024 09:47 ET
|
American Kidney Fund
ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week™, the nation’s only free online conference that draws patients,...
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
March 15, 2024 08:59 ET
|
American Kidney Fund
ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate...